Premium
Cavernous hemangioma of the breast: Mammographic and sonographic findings and follow‐up in a patient receiving hormone‐replacement therapy
Author(s) -
Mesurolle Benoît,
Wexler Marvin,
Halwani Fawaz,
Aldis Ann,
Veksler Anna,
Kao Ellen
Publication year - 2003
Publication title -
journal of clinical ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.272
H-Index - 61
eISSN - 1097-0096
pISSN - 0091-2751
DOI - 10.1002/jcu.10193
Subject(s) - medicine , benignity , nodule (geology) , mammography , radiology , biopsy , hemangioma , ultrasound , angioma , surgery , malignancy , vascular disease , breast cancer , cancer , pathology , paleontology , biology
We report the case of a 78‐year‐old woman who had been receiving hormone‐replacement therapy (HRT) for 6 years and had a 4‐month history of a painless nodule in the 9 o'clock position in her right breast. Mammography performed 4 years previously had shown a 4‐mm bilobed, ovoid, well‐defined nodule in that location; mammography performed 1 year previously had shown that the nodule had increased to 6 mm. We performed mammographic and sonographic examinations, which revealed a 10‐mm ovoid nodule in the same 9 o'clock position in the right breast. The imaging findings appeared to indicate benignity, but because of the increasing size of the nodule, we undertook an ultrasound‐guided large‐core needle biopsy. The histopathologic diagnosis was typical cavernous hemangioma. It was not excised, but HRT was discontinued. Follow‐up mammography and sonography 8 months later showed that the nodule had decreased to 6 mm. We believe that the HRT played a contributory role in the increasing size of this patient's cavernous hemangioma. The use of ultrasound‐guided large‐core needle biopsy is reliable enough to ascertain the benignity of such masses and can thus avoid, if it is clinically appropriate, the need for their surgical removal. © 2003 Wiley Periodicals, Inc. J Clin Ultrasound 31:430–436, 2003